[HTML][HTML] Ovarian cancer

T Arora, S Mullangi, MR Lekkala - 2021 - europepmc.org
Objectives: Describe the epidemiology of ovarian cancer. Review the evaluation of a patient
with suspected ovarian cancer. Summarize the treatment options of ovarian cancer. Outline …

Advances in diagnosis and treatment of bladder cancer

A Lopez-Beltran, MS Cookson, BJ Guercio, L Cheng - bmj, 2024 - bmj.com
Bladder cancer remains a leading cause of cancer death worldwide and is associated with
substantial impacts on patient quality of life, morbidity, mortality, and cost to the healthcare …

A cell-free DNA blood-based test for colorectal cancer screening

DC Chung, DM Gray, H Singh, RB Issaka… - … England Journal of …, 2024 - Mass Medical Soc
Background Colorectal cancer is the third most diagnosed cancer in adults in the United
States. Early detection could prevent more than 90% of colorectal cancer–related deaths, yet …

Cancer statistics 2024: All hands on deck.

DS Dizon, AH Kamal - CA: a cancer journal for clinicians, 2024 - search.ebscohost.com
Abstract The 2024 update to Cancer Statistics from the American Cancer Society reveals
that over 2 million people in the United States will be diagnosed with cancer this year. This …

Non–Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

GJ Riely, DE Wood, DS Ettinger, DL Aisner… - Journal of the National …, 2024 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC …

NCCN guidelines® insights: Melanoma: Cutaneous, version 2.2024: Featured updates to the NCCN guidelines

SM Swetter, D Johnson, MR Albertini… - Journal of the National …, 2024 - jnccn.org
The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide
multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients …

Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer

P Marino, M Mininni, G Deiana, G Marino, R Divella… - Nutrients, 2024 - mdpi.com
Cancer has become a serious problem worldwide, as it represents the main cause of death,
and its incidence has increased over the years. A potential strategy to counter the growing …

Claudin18. 2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

C Qi, C Liu, J Gong, D Liu, X Wang, P Zhang, Y Qin… - Nature Medicine, 2024 - nature.com
Abstract Claudin18. 2 (CLDN18. 2) is highly expressed with the development of various
malignant tumors, especially gastrointestinal cancers, and is emerging as a new target for …

[HTML][HTML] Optimization of chemotherapy regimens using mathematical programming

K Bräutigam - Computers & Industrial Engineering, 2024 - Elsevier
Cancer is a leading cause of death and a cost burden on healthcare systems worldwide.
The mainstay of treatment is chemotherapy which is most often administered empirically …

[HTML][HTML] Actinium-225 targeted alpha particle therapy for prostate cancer

AP Bidkar, L Zerefa, S Yadav, HF VanBrocklin… - Theranostics, 2024 - ncbi.nlm.nih.gov
Targeted alpha particle therapy (TAT) has emerged as a promising strategy for the treatment
of prostate cancer (PCa). Actinium-225 (225 Ac), a potent alpha-emitting radionuclide, may …